82 related articles for article (PubMed ID: 2592856)
21. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
Rosenberg MJ; Waugh MS; Long S
J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
[TBL] [Abstract][Full Text] [Related]
22. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
23. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives in 1984.
Chapler EK
Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
[TBL] [Abstract][Full Text] [Related]
25. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
Gordon EM; Douglas J; Ratnoff OD
J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187
[TBL] [Abstract][Full Text] [Related]
26. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
27. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
Spellacy WN; Ellingson AB; Tsibris JC
J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
[TBL] [Abstract][Full Text] [Related]
28. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
29. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
30. Factor seven ativating potease (FSAP) levels during normal pregnancy and in women using oral contraceptives.
Parahuleva MS; Hölschermann H; Erdogan A; Langanke E; Prickartz I; Parviz B; Weiskirchen R; Tillmanns H; Kanse SM
Thromb Res; 2010 Jul; 126(1):e36-40. PubMed ID: 20381831
[TBL] [Abstract][Full Text] [Related]
31. Effect of various estrogen treatment schedules on antithrombin III levels.
Ambrus JL; Ambrus CM; Lillie MA; Browne BJ; Hanson FW; Niswander K; Witul M; Jung OS; Bartfay-Szabo A
Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):543-9. PubMed ID: 959656
[TBL] [Abstract][Full Text] [Related]
32. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
Tran TH; Zbinden B; Lämmle B; Duckert F
Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
[TBL] [Abstract][Full Text] [Related]
33. The influence of estrogen and prolactin on Hageman factor (factor XII) titer in ovariectomized and hypophysectomized rats.
Gordon EM; Douglas JG; Ratnoff OD; Arafah BM
Blood; 1985 Sep; 66(3):602-5. PubMed ID: 4027381
[TBL] [Abstract][Full Text] [Related]
34. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency.
Tollefsen DM
Semin Thromb Hemost; 1990 Apr; 16(2):162-8. PubMed ID: 2191430
[TBL] [Abstract][Full Text] [Related]
35. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin.
Whitfield LR; Lele AS; Levy G
Clin Pharmacol Ther; 1983 Jul; 34(1):23-8. PubMed ID: 6861435
[TBL] [Abstract][Full Text] [Related]
36. Augmented Hageman factor and prolactin titers, enhanced cold activation of factor VII, and spontaneous shortening of prothrombin time in survivors of myocardial infarction.
Gordon EM; Hellerstein HK; Ratnoff OD; Arafah BM; Yamashita TS
J Lab Clin Med; 1987 Apr; 109(4):409-13. PubMed ID: 3493315
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of plasma protein S in pregnancy].
Cheng DW
Zhonghua Fu Chan Ke Za Zhi; 1989 Jul; 24(4):217-9, 252. PubMed ID: 2533549
[TBL] [Abstract][Full Text] [Related]
38. Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age.
Fischer JH; Sarto GE; Habibi M; Kilpatrick SJ; Tuomala RE; Shier JM; Wollett L; Fischer PA; Khorana KS; Rodvold KA
Antimicrob Agents Chemother; 2012 Feb; 56(2):715-24. PubMed ID: 22106226
[TBL] [Abstract][Full Text] [Related]
39. [Heparin cofactor II (HC II)].
Suzuki K
Nihon Rinsho; 1999 Sep; 57 Suppl():633-5. PubMed ID: 10543198
[No Abstract] [Full Text] [Related]
40. [Heparin cofactor II (HC II)].
Takeya H; Suzuki K
Nihon Rinsho; 1995 Mar; 53 Su Pt 2():122-4. PubMed ID: 8753197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
